Estados Unidos · Revistas de economía · Quartz

3 next-generation weight-loss drugs at different stages of FDA review and trials

Publicado por Quartz · Estados Unidos hace 2 h

The next weight-loss drugs to watch are CagriSema, retatrutide and aleniglipron, three obesity candidates at different stages of testing and FDA review, and only one has been filed

Leer el artículo completo en Quartz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (qz.com)

3 next-generation weight-loss drugs at different stages of FDA review and trials

También te puede interesar

The Johns Hopkins Breach Wasn’t Caused by a Hacker. It Started With 1 Employee Upload

The AI Boom Has a Warning System. Here's What It's Saying Now

Nelson Peltz-led group offers to buy Wendy’s for $1.4B

Daylight saving time is spooky this year: What to know about the 2026 clock change

McDonald’s Says There’s Such a Thing as a Bad Big Mac. Now It’s Training 2 Million Workers to Taste the Difference.

What Multiplier's talent trends reveal about the future of work

3 next-generation weight-loss drugs at different stages of FDA review and trials

Compartir

También te puede interesar

The Johns Hopkins Breach Wasn’t Caused by a Hacker. It Started With 1 Employee Upload

The AI Boom Has a Warning System. Here's What It's Saying Now

Nelson Peltz-led group offers to buy Wendy’s for $1.4B

Daylight saving time is spooky this year: What to know about the 2026 clock change

McDonald’s Says There’s Such a Thing as a Bad Big Mac. Now It’s Training 2 Million Workers to Taste the Difference.

What Multiplier's talent trends reveal about the future of work